Patients Choice Labs selects 1health to Launch Genetic Testing to Consumers

Close-up of researcher using pipette to pour the blue liquid in test tubes at table in laboratory

With technology, Patients Choice Laboratories customers will be able to order tests online

The direct-to-consumer lab testing market is forecast to grow at a 22% compound annual growth from 2021 to 2031, according to research group, Transparency Marketing in its report “North America Direct-to-Consumer Laboratory Testing Market Insights, 2021-2031” published Q1 2022, hitting an $8.8 billion valuation at the end of this decade.

PCL plans to bring its proprietary PGx test, one that encompasses more than 200 medications by determining how a person’s genetic makeup metabolizes them, to the 1health platform later this year. Besides understanding how a patient’s unique body responds to common medications, which can be life-saving all on its own, there are other important benefits to PGx testing which include helping patients with chronic conditions manage their drug regimen, decreasing the need for trial-and-error dosing, and reducing overall health care costs.

“We had been looking for more than a year to find a provider to help us go-to-market directly to consumers,” states Brad Moss, President of PCL. “The direct-to-consumer market is a growing and a strategic target for us. We look forward to going live with our innovative PGx test later this year on the 1health platform,” continued Moss.

“Having Patients Choice Laboratories on the 1health platform means their customers will be able to order PCL lab tests online and intuitively- in minutes, not days or weeks. In addition, PCL customers will be able to understand the bioinformatics and reporting within the 1health platform, providing a comprehensive way to view and understand treatment recommendations quickly,” states 1health CEO Mehdi Maghsoodnia. “We are proud they have selected 1health as their go-to-market platform for their physicians, clinicians, and patients,” added Maghsoodnia.

To read the press release click HERE

To learn more about Patients Choice go to their website at Patients Choice Laboratories | Advanced Medical Laboratory Testing | Indianapolis (

Latest Posts

Advances in Pharmacogenomic Testing

According to Straits Research, the pharmacogenomics market is $5.7 billion dollars, and is expected to grow at a CAGR of 8.47% this decade


GC LabTech Launches Partnership with 1health to Deploy Innovative Lab Tests

Next generation 1health technology enables GC LabTech to quickly launch differentiated testing products to consumers


American Molecular Labs selects 1health for its DTC Test and Ordering Platform

Using 1health, American Molecular Labs will deploy its proprietary tests to consumers, clinicians & partner companies


Championing PGx and CGx Screening

How Independent labs can grow by selling advanced screening procedures and support the US Cancer Moonshot Initiative.


Minimizing the Impact of Laboratory Staff Shortages in 2023 and Beyond

Clinical staff shortage is impacting the entire healthcare industry. How does the laboratory industry survive and thrive?


Learn how 1health can power your growth.